www.madrigalpharma.com
Open in
urlscan Pro
2606:4700:20::681a:7dc
Public Scan
Submitted URL: https://www.madrigalpharma.org/
Effective URL: https://www.madrigalpharma.com/
Submission: On June 26 via api from US — Scanned from DE
Effective URL: https://www.madrigalpharma.com/
Submission: On June 26 via api from US — Scanned from DE
Form analysis
1 forms found in the DOMGET https://www.madrigalpharma.com/
<form action="https://www.madrigalpharma.com/" method="get" class="searchform search-layout-simple">
<div class="searchform-fields">
<span class="text"><input name="s" type="text" value="" placeholder="Search…" autocomplete="off"></span>
<span class="button-wrap">
<button class="btn btn-special" title="Search" type="submit">
<i class="porto-icon-magnifier"></i>
</button>
</span>
</div>
<div class="live-search-list"></div>
</form>
Text Content
* About Us * Overview * Leadership * Board of Directors * Our Programs * Overview * Our Medicine * NASH * Overview * Resources * Investors & Media * Overview * Press Releases * Events and Presentations * Financials and Filings * Stock Information * Corporate Governance * FAQs * Careers * Join the team * Contact * General Inquires * Medical Information Inquiries * Medical Education Grant Requests Search * About Us * Overview * Leadership * Board of Directors * Our Programs * Overview * Our Medicine * NASH * Overview * Resources * Investors & Media * Overview * Press Releases * Events and Presentations * Financials and Filings * Stock Information * Corporate Governance * FAQs * Careers * Join the team * Contact * General Inquires * Medical Information Inquiries * Medical Education Grant Requests A COMPANY FOCUSED ON IMPROVING CARE FOR PATIENTS WITH NASH/MASH. Learn More PURSUING NOVEL THERAPEUTICS TARGETING NASH/MASH Madrigal is a biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH). Our first therapy was granted accelerated approval by the U.S. Food and Drug Administration (FDA) for the treatment of adults with NASH with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis) and is being studied in a Phase 3 trial for the treatment of NASH with compensated cirrhosis. NEWS JUNE 06, 2024 Madrigal Pharmaceuticals Announces New Data from the Phase 3 MAESTRO-NASH Study of Rezdiffra™ (resmetirom) Presented at the EASL Congress JUNE 05, 2024 Madrigal Pharmaceuticals to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference PRESS RELEASES > EVENTS JUNE 11, 2024 Goldman Sachs 45th Annual Global Healthcare Conference Listen to Webcast EVENTS & PRESENTATIONS > MADRIGAL’S AMBITIOUS RESEARCH PROGRAMS LED TO THE FIRST FDA-APPROVED TREATMENT FOR NASH. Learn More Madrigal Pharmaceuticals 200 Barr Harbor Drive, Suite 200 West Conshohocken, Pennsylvania 19428 Madrigal LinkedIn Madrigal Twitter * About Us * Our Programs * NASH * Investors & Media * Careers * Contact * TERMS OF USE * PRIVACY * COOKIES * ETHICS and COMPLIANCE * TRANSPARENCY ©2024 Madrigal Pharmaceuticals. All rights reserved. We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent. Cookie SettingsAccept All Manage consent Close PRIVACY OVERVIEW This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the ... Necessary Necessary Always Enabled Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously. CookieDurationDescriptioncookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. Functional Functional Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features. Performance Performance Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors. Analytics Analytics Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc. Advertisement Advertisement Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads. Others Others Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet. SAVE & ACCEPT * * READ THE REZDIFFRA PRESS RELEASE * ACCESS THE REZDIFFRA PRESCRIBING INFORMATION * ACCESS THE REZDIFFRA PATIENT PRESCRIBING INFORMATION * PATIENTS VISIT REZDIFFRA.COM TO LEARN MORE * HEALTHCARE PROVIDERS VISIT REZDIFFRAHCP.COM TO LEARN MORE ×